Your browser doesn't support javascript.
loading
The clinical significance of fibrinogen plasma levels in patients with diffuse large B cell lymphoma.
Troppan, Katharina T; Melchardt, Thomas; Wenzl, Kerstin; Schlick, Konstantin; Deutsch, Alexander; Bullock, Marc D; Reitz, Daniel; Beham-Schmid, Christine; Weiss, Lukas; Neureiter, Daniel; Tränkenschuh, Wolfgang; Greil, Richard; Neumeister, Peter; Egle, Alexander; Pichler, Martin.
Afiliação
  • Troppan KT; Division of Hematology, Department of Internal Medicine, Medical University of Graz (MUG), Graz, Austria.
  • Melchardt T; 3rd Medical Department with Hematology and Medical Oncology, Hemostaseology, Rheumatology and Infectious Diseases, Laboratory for Immunological and Molecular Cancer Research, Oncologic Center, Paracelsus Medical University Salzburg, Graz, Austria.
  • Wenzl K; Division of Hematology, Department of Internal Medicine, Medical University of Graz (MUG), Graz, Austria.
  • Schlick K; 3rd Medical Department with Hematology and Medical Oncology, Hemostaseology, Rheumatology and Infectious Diseases, Laboratory for Immunological and Molecular Cancer Research, Oncologic Center, Paracelsus Medical University Salzburg, Graz, Austria.
  • Deutsch A; Division of Hematology, Department of Internal Medicine, Medical University of Graz (MUG), Graz, Austria.
  • Bullock MD; Department of Experimental Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Reitz D; Division of Oncology, Department of Internal Medicine, Medical University of Graz (MUG), Graz, Austria.
  • Beham-Schmid C; Institute of Pathology, Medical University of Graz (MUG), Graz, Austria.
  • Weiss L; 3rd Medical Department with Hematology and Medical Oncology, Hemostaseology, Rheumatology and Infectious Diseases, Laboratory for Immunological and Molecular Cancer Research, Oncologic Center, Paracelsus Medical University Salzburg, Graz, Austria.
  • Neureiter D; Institute of Pathology, Paracelsus Medical University Salzburg, Salzburg, Austria.
  • Tränkenschuh W; Institute of Pathology, Paracelsus Medical University Salzburg, Salzburg, Austria.
  • Greil R; 3rd Medical Department with Hematology and Medical Oncology, Hemostaseology, Rheumatology and Infectious Diseases, Laboratory for Immunological and Molecular Cancer Research, Oncologic Center, Paracelsus Medical University Salzburg, Graz, Austria.
  • Neumeister P; Division of Hematology, Department of Internal Medicine, Medical University of Graz (MUG), Graz, Austria.
  • Egle A; 3rd Medical Department with Hematology and Medical Oncology, Hemostaseology, Rheumatology and Infectious Diseases, Laboratory for Immunological and Molecular Cancer Research, Oncologic Center, Paracelsus Medical University Salzburg, Graz, Austria.
  • Pichler M; Department of Experimental Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
J Clin Pathol ; 69(4): 326-30, 2016 Apr.
Article em En | MEDLINE | ID: mdl-26644520
Assuntos
Palavras-chave
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Fibrinogênio / Biomarcadores Tumorais / Linfoma Difuso de Grandes Células B Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Idioma: En Revista: J Clin Pathol Ano de publicação: 2016 Tipo de documento: Article País de afiliação: Áustria
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Fibrinogênio / Biomarcadores Tumorais / Linfoma Difuso de Grandes Células B Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Idioma: En Revista: J Clin Pathol Ano de publicação: 2016 Tipo de documento: Article País de afiliação: Áustria